IFM Therapeutics
Vincent Miles is the current director at IFM Therapeutics. Vincent has held previous positions as Senior VP of Business Development at Alnylam Pharmaceuticals from July 2003 to March 2007, VP of Business Development and Technology Management at Millennium Pharmaceuticals from May 1997 to July 2003, Director of the Office of Technology Transfer at Dana Farber Cancer Institute from February 1996 to May 1997, VP of International Marketing at Pharmacia Biotech from August 1986 to April 1992, and VP of R&D and Business Development at RiboGene from April 1992 to January 1996. Prior to their work in the private sector, Vincent served as a Higher Scientific Officer at the Home Office Forensic Science Laboratory from October 1975 to February 1978.
Vincent Miles received a B.Sc. in biochemistry from UCL and a Ph.D. in biochemical embryology/molecular biology from the same school.
This person is not in the org chart
This person is not in any teams
IFM Therapeutics
At IFM Therapeutics, they work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body’s first line of immunological response, and an essential component of immune function.